2026 NPPES data Ophthalmology Physician NPI 1780607622 MD
Verify on CMS →

NATALIE LOPASIC, MD

Ophthalmology Physician in LATHAM, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 1K beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
51%
generic claims · 49% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
7.0671/100
▼ 76 pts below national avg 83.1 · [object Object]
Industry payments
$561.37
27 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NATALIE LOPASIC, MD reported a CMS MIPS final score of 7.0671/100 — below the 83.1 national average — and filed 3,382 Medicare Part D claims in 2023.

7.0671/100
MIPS score · -76 vs avg
3K
Part D claims, 2023
51%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NATALIE LOPASIC, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

7 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NATALIE LOPASIC, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NATALIE LOPASIC, MD?

Below national average

NPI registry status

Active

Issued 07/25/2006

NPI 1780607622

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

3,382 138% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

7.0671/100 76.0329% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in New York

How Ophthalmology Physician compares to other specialties among New York providers

New York providers

Ophthalmology Physician share within New York

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within New York

Medicare quality performance — MIPS

NATALIE LOPASIC, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average

Below national average
MIPS Final Score
7.0671/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 7.0671/100 vs national avg 83.1

0%100%National avg83%7.1%
MIPS final score (Ophthalmology Physician) — 7.0671/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NATALIE LOPASIC, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 767 TROY SCHENECTADY RD STE 1, LATHAM, NY, 12110, with a listed phone of (518) 690-7020. NPI 1780607622 was issued on 07/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LOPASIC most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,382 prescription claims written by this provider, covering 1,005 Medicare beneficiaries and totaling roughly $672K in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 7.0671/100 for the 2023 performance year (Quality 0, Cost 23.557), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

767 TROY SCHENECTADY RD STE 1
LATHAM, NY 12110

Provider Details

NPI 1780607622
Specialty Ophthalmology Physician
Credentials MD
Gender Female
NPI Issued 07/25/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

7.0671
Final Score
Avg: 83.1
0
Quality
23.557
Cost

Reporting: Individual

Hospital and facility affiliations

Facilities where NATALIE LOPASIC, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NATALIE W LOPASIC
LATHAM, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NATALIE LOPASIC, MD. Source: openpaymentsdata.cms.gov.

Total received

$561

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to NATALIE LOPASIC, MD. To verify NATALIE LOPASIC, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

NATALIE LOPASIC, MD — brand share 49.0%
Specialty average (est.)

49% brand-name claims vs 51% generic, on 3,382 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,382
Total Claims
$672K
Total Drug Cost
1,005
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,565
Total Day Supply
148,378
Brand vs Generic
49% brand / 51% generic
Brand Drug Cost
$611K
Generic Drug Cost
$61K
Antibiotic Claims
74

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
1.10
Gender Split
65% female / 35% male
Age Distribution
<65: 77, 65-74: 479, 75-84: 365, 85+: 84

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NATALIE LOPASIC, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
557
Latanoprost
400
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
349
Lumigan
Bimatoprost
303
Ciprofloxacin Hcl
295
Ketorolac Tromethamine
295
Erythromycin
Erythromycin Base
218
Timolol Maleate
218
Restasis
Cyclosporine
128
Doxycycline Hyclate
60

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How NATALIE LOPASIC, MD fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

NATALIE LOPASIC, MD's 3,382 claims are above the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as LOPASIC.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NATALIE LOPASIC, MD's specialty?
NATALIE LOPASIC, MD specializes in Ophthalmology Physician and practices in LATHAM, New York. Credentials: MD.
How much does NATALIE LOPASIC, MD prescribe under Medicare Part D?
In 2023, NATALIE LOPASIC, MD wrote 3,382 Medicare Part D claims totaling $672K in drug costs for 1,005 beneficiaries.
What is NATALIE LOPASIC, MD's Medicare quality score?
NATALIE LOPASIC, MD has a CMS MIPS Final Score of 7.0671/100 (Quality: 0, Cost: 23.557). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NATALIE LOPASIC, MD located?
NATALIE LOPASIC, MD is located at 767 TROY SCHENECTADY RD STE 1, LATHAM, NY, 12110. Phone: (518) 690-7020.
What is NATALIE LOPASIC, MD's NPI number?
NATALIE LOPASIC, MD's National Provider Identifier (NPI) is 1780607622, issued on 07/25/2006.
Does NATALIE LOPASIC, MD prescribe more brand-name or generic drugs?
NATALIE LOPASIC, MD's prescribing is 49% brand-name and 51% generic drugs by claim count, with $611K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does NATALIE LOPASIC, MD prescribe most often?
Based on 2023 Medicare Part D data, NATALIE LOPASIC, MD's most frequently prescribed drugs include Prednisolone Acetate, Latanoprost, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NATALIE LOPASIC, MD accept Medicare?
NATALIE LOPASIC, MD appears in CMS Medicare data with 3,382 Part D claims and 1,005 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NATALIE LOPASIC, MD's credentials?
NATALIE LOPASIC, MD's NPI is 1780607622 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology